NEUROFIBROMATOSIS TYPE 2
Clinical trials for NEUROFIBROMATOSIS TYPE 2 explained in plain language.
Never miss a new study
Get alerted when new NEUROFIBROMATOSIS TYPE 2 trials appear
Sign up with your email to follow new studies for NEUROFIBROMATOSIS TYPE 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common antibiotic shrink NF2 skin tumors without surgery?
Disease control OngoingThis study tests whether injecting doxycycline directly into skin tumors (schwannomas) can shrink them in people with neurofibromatosis type 2 (NF2). About 19 participants will receive the injections, and doctors will measure tumor size changes over time. The goal is to find a le…
Matched conditions: NEUROFIBROMATOSIS TYPE 2
Phase: PHASE1, PHASE2 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated May 17, 2026 07:07 UTC
-
New drug cocktail trial aims to tame tough tumors
Disease control OngoingThis early-phase trial tests the safety and best doses of two drugs (bevacizumab and temsirolimus) given alone or with other medicines (valproic acid or cetuximab) in people with advanced cancer or certain non-cancerous diseases that are hard to treat. The goal is to find the hig…
Matched conditions: NEUROFIBROMATOSIS TYPE 2
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:06 UTC